Myocardial Recovery in Peripartum Cardiomyopathy After Hyperprolactinemia Treatment on BIVAD

  • Dominik Wiedemann
  • , Thomas Schlöglhofer
  • , Julia Riebandt
  • , Markus Neuner
  • , Edda Tschernko
  • , Heinrich Schima
  • , Daniel Zimpfer

Research output: Journal article (peer-reviewed)Journal article

Abstract

Peripartum cardiomyopathy (PPCMP) requiring mechanical circulatory support is rare; however, it is a life-threatening disease with recovery rates poorer than expected. Herein, we describe a case of successful recovery of a patient with PPCMP. Implantation of a biventricular ventricular assist device was performed; additionally, the patient's hyperprolactinemia was treated with cabergoline, resulting in a fast complete restoration of ventricular function.

Original languageEnglish
Pages (from-to)109-111
Number of pages3
JournalASAIO Journal
Volume63
Issue number1
DOIs
Publication statusPublished - 01 Jan 2017
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adult
  • Cardiomyopathies/physiopathology
  • Female
  • Heart Ventricles/physiopathology
  • Heart-Assist Devices
  • Humans
  • Hyperprolactinemia/drug therapy
  • Pregnancy
  • Puerperal Disorders/physiopathology

Fingerprint

Dive into the research topics of 'Myocardial Recovery in Peripartum Cardiomyopathy After Hyperprolactinemia Treatment on BIVAD'. Together they form a unique fingerprint.

Cite this